To circumvent this unfavourable outcome, Perez and David et al. used siRNA to deplete the MDR1 mRNA and sensitize ovarian and lung cancer cells to chemotherapy 31, 32, 33. This evidence concerns the gene ABCB1 and lung carcinoma.